Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited (SBHMY) Stock Competitors & Peer Comparison
See (SBHMY) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SBHMY | $18.65 | +6.57% | 16.7B | 64.31 | $0.29 | +1.02% |
| NONOF | $68.80 | -1.63% | 310.1B | 18.83 | $3.71 | +2.37% |
| CSLLY | $87.92 | -0.27% | 170.3B | 32.33 | $2.72 | +1.50% |
| CMXHF | $173.00 | -1.54% | 83.8B | 31.74 | $5.45 | +1.52% |
| UCBJF | $211.99 | -0.73% | 40.3B | 32.87 | $6.45 | +0.73% |
| UCBJY | $103.49 | -1.32% | 39.7B | 32.19 | $3.23 | +0.75% |
| ARGNF | $547.18 | -0.08% | 33.5B | 33.43 | $16.37 | N/A |
| ODTC | $22,005.00 | +29.44% | 24.1B | 1.07 | $20,580.00 | N/A |
| IVBXF | $12.07 | +4.96% | 20.8B | -1215.00 | -$0.01 | N/A |
| WXIBF | $4.05 | +1.25% | 16.5B | 36.77 | $0.11 | N/A |
Stock Comparison
SBHMY vs NONOF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, NONOF has a market cap of 310.1B. Regarding current trading prices, SBHMY is priced at $18.65, while NONOF trades at $68.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas NONOF's P/E ratio is 18.83. In terms of profitability, SBHMY's ROE is +0.11%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, SBHMY is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check NONOF's competition here
SBHMY vs CSLLY Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, CSLLY has a market cap of 170.3B. Regarding current trading prices, SBHMY is priced at $18.65, while CSLLY trades at $87.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas CSLLY's P/E ratio is 32.33. In terms of profitability, SBHMY's ROE is +0.11%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, SBHMY is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check CSLLY's competition here
SBHMY vs CMXHF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, CMXHF has a market cap of 83.8B. Regarding current trading prices, SBHMY is priced at $18.65, while CMXHF trades at $173.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas CMXHF's P/E ratio is 31.74. In terms of profitability, SBHMY's ROE is +0.11%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, SBHMY and CMXHF have similar daily volatility (0.00).Check CMXHF's competition here
SBHMY vs UCBJF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, UCBJF has a market cap of 40.3B. Regarding current trading prices, SBHMY is priced at $18.65, while UCBJF trades at $211.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas UCBJF's P/E ratio is 32.87. In terms of profitability, SBHMY's ROE is +0.11%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, SBHMY and UCBJF have similar daily volatility (0.00).Check UCBJF's competition here
SBHMY vs UCBJY Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, UCBJY has a market cap of 39.7B. Regarding current trading prices, SBHMY is priced at $18.65, while UCBJY trades at $103.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas UCBJY's P/E ratio is 32.19. In terms of profitability, SBHMY's ROE is +0.11%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, SBHMY is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check UCBJY's competition here
SBHMY vs ARGNF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, ARGNF has a market cap of 33.5B. Regarding current trading prices, SBHMY is priced at $18.65, while ARGNF trades at $547.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas ARGNF's P/E ratio is 33.43. In terms of profitability, SBHMY's ROE is +0.11%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, SBHMY is less volatile compared to ARGNF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check ARGNF's competition here
SBHMY vs ODTC Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, SBHMY is priced at $18.65, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas ODTC's P/E ratio is 1.07. In terms of profitability, SBHMY's ROE is +0.11%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, SBHMY and ODTC have similar daily volatility (0.00).Check ODTC's competition here
SBHMY vs IVBXF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, IVBXF has a market cap of 20.8B. Regarding current trading prices, SBHMY is priced at $18.65, while IVBXF trades at $12.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas IVBXF's P/E ratio is -1215.00. In terms of profitability, SBHMY's ROE is +0.11%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, SBHMY is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check IVBXF's competition here
SBHMY vs WXIBF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, WXIBF has a market cap of 16.5B. Regarding current trading prices, SBHMY is priced at $18.65, while WXIBF trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas WXIBF's P/E ratio is 36.77. In terms of profitability, SBHMY's ROE is +0.11%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, SBHMY and WXIBF have similar daily volatility (0.00).Check WXIBF's competition here
SBHMY vs WXXWY Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, WXXWY has a market cap of 16.4B. Regarding current trading prices, SBHMY is priced at $18.65, while WXXWY trades at $8.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas WXXWY's P/E ratio is 36.59. In terms of profitability, SBHMY's ROE is +0.11%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, SBHMY is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check WXXWY's competition here
SBHMY vs SBMFF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, SBMFF has a market cap of 16B. Regarding current trading prices, SBHMY is priced at $18.65, while SBMFF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas SBMFF's P/E ratio is 89.21. In terms of profitability, SBHMY's ROE is +0.11%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, SBHMY and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
SBHMY vs GNMSF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, GNMSF has a market cap of 14.1B. Regarding current trading prices, SBHMY is priced at $18.65, while GNMSF trades at $229.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas GNMSF's P/E ratio is 13.46. In terms of profitability, SBHMY's ROE is +0.11%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, SBHMY is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check GNMSF's competition here
SBHMY vs TRSBF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, TRSBF has a market cap of 8.8B. Regarding current trading prices, SBHMY is priced at $18.65, while TRSBF trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas TRSBF's P/E ratio is 31.00. In terms of profitability, SBHMY's ROE is +0.11%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, SBHMY and TRSBF have similar daily volatility (0.00).Check TRSBF's competition here
SBHMY vs HAVLF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, HAVLF has a market cap of 5.6B. Regarding current trading prices, SBHMY is priced at $18.65, while HAVLF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas HAVLF's P/E ratio is -0.01. In terms of profitability, SBHMY's ROE is +0.11%, compared to HAVLF's ROE of +0.00%. Regarding short-term risk, SBHMY and HAVLF have similar daily volatility (0.00).Check HAVLF's competition here
SBHMY vs ABCZF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, SBHMY is priced at $18.65, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, SBHMY's ROE is +0.11%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, SBHMY and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
SBHMY vs AKBLF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, AKBLF has a market cap of 5B. Regarding current trading prices, SBHMY is priced at $18.65, while AKBLF trades at $22.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas AKBLF's P/E ratio is 33.86. In terms of profitability, SBHMY's ROE is +0.11%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, SBHMY and AKBLF have similar daily volatility (0.00).Check AKBLF's competition here
SBHMY vs GNNSF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, GNNSF has a market cap of 5B. Regarding current trading prices, SBHMY is priced at $18.65, while GNNSF trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas GNNSF's P/E ratio is -28.87. In terms of profitability, SBHMY's ROE is +0.11%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, SBHMY and GNNSF have similar daily volatility (0.00).Check GNNSF's competition here
SBHMY vs INCPF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, SBHMY is priced at $18.65, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas INCPF's P/E ratio is -108.67. In terms of profitability, SBHMY's ROE is +0.11%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, SBHMY and INCPF have similar daily volatility (0.00).Check INCPF's competition here
SBHMY vs TLPPF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, TLPPF has a market cap of 4.6B. Regarding current trading prices, SBHMY is priced at $18.65, while TLPPF trades at $13.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas TLPPF's P/E ratio is 137.00. In terms of profitability, SBHMY's ROE is +0.11%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, SBHMY is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check TLPPF's competition here
SBHMY vs LABFF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, SBHMY is priced at $18.65, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas LABFF's P/E ratio is 28.95. In terms of profitability, SBHMY's ROE is +0.11%, compared to LABFF's ROE of +0.38%. Regarding short-term risk, SBHMY and LABFF have similar daily volatility (0.00).Check LABFF's competition here
SBHMY vs AAVXF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, AAVXF has a market cap of 4.2B. Regarding current trading prices, SBHMY is priced at $18.65, while AAVXF trades at $66.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas AAVXF's P/E ratio is -19.25. In terms of profitability, SBHMY's ROE is +0.11%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, SBHMY and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
SBHMY vs ZLDPF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, ZLDPF has a market cap of 4.1B. Regarding current trading prices, SBHMY is priced at $18.65, while ZLDPF trades at $58.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas ZLDPF's P/E ratio is -21.32. In terms of profitability, SBHMY's ROE is +0.11%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, SBHMY and ZLDPF have similar daily volatility (0.00).Check ZLDPF's competition here
SBHMY vs CAMRF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, SBHMY is priced at $18.65, while CAMRF trades at $56.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas CAMRF's P/E ratio is 44.88. In terms of profitability, SBHMY's ROE is +0.11%, compared to CAMRF's ROE of +0.17%. Regarding short-term risk, SBHMY is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check CAMRF's competition here
SBHMY vs GLPGF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, GLPGF has a market cap of 3.2B. Regarding current trading prices, SBHMY is priced at $18.65, while GLPGF trades at $48.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas GLPGF's P/E ratio is -9.44. In terms of profitability, SBHMY's ROE is +0.11%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, SBHMY is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check GLPGF's competition here
SBHMY vs REGMF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, REGMF has a market cap of 3B. Regarding current trading prices, SBHMY is priced at $18.65, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas REGMF's P/E ratio is -13.32. In terms of profitability, SBHMY's ROE is +0.11%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, SBHMY is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check REGMF's competition here
SBHMY vs BVNKF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, BVNKF has a market cap of 2.9B. Regarding current trading prices, SBHMY is priced at $18.65, while BVNKF trades at $37.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas BVNKF's P/E ratio is 14.19. In terms of profitability, SBHMY's ROE is +0.11%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, SBHMY and BVNKF have similar daily volatility (0.00).Check BVNKF's competition here
SBHMY vs BVNRY Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, BVNRY has a market cap of 2.9B. Regarding current trading prices, SBHMY is priced at $18.65, while BVNRY trades at $12.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas BVNRY's P/E ratio is 13.90. In terms of profitability, SBHMY's ROE is +0.11%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, SBHMY is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check BVNRY's competition here
SBHMY vs TKBIF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, SBHMY is priced at $18.65, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, SBHMY's ROE is +0.11%, compared to TKBIF's ROE of N/A. Regarding short-term risk, SBHMY and TKBIF have similar daily volatility (0.00).Check TKBIF's competition here
SBHMY vs MPSYF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, SBHMY is priced at $18.65, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, SBHMY's ROE is +0.11%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, SBHMY is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check MPSYF's competition here
SBHMY vs ONTTF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, ONTTF has a market cap of 2.7B. Regarding current trading prices, SBHMY is priced at $18.65, while ONTTF trades at $2.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas ONTTF's P/E ratio is -12.77. In terms of profitability, SBHMY's ROE is +0.11%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, SBHMY is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check ONTTF's competition here
SBHMY vs ASPHF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, ASPHF has a market cap of 2.4B. Regarding current trading prices, SBHMY is priced at $18.65, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, SBHMY's ROE is +0.11%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, SBHMY is less volatile compared to ASPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check ASPHF's competition here
SBHMY vs GENSF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, GENSF has a market cap of 2.2B. Regarding current trading prices, SBHMY is priced at $18.65, while GENSF trades at $33.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas GENSF's P/E ratio is -416.12. In terms of profitability, SBHMY's ROE is +0.11%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, SBHMY and GENSF have similar daily volatility (0.00).Check GENSF's competition here
SBHMY vs SHJBF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, SHJBF has a market cap of 2B. Regarding current trading prices, SBHMY is priced at $18.65, while SHJBF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas SHJBF's P/E ratio is -7.22. In terms of profitability, SBHMY's ROE is +0.11%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, SBHMY is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check SHJBF's competition here
SBHMY vs IUGNF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, IUGNF has a market cap of 1.9B. Regarding current trading prices, SBHMY is priced at $18.65, while IUGNF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas IUGNF's P/E ratio is -26.00. In terms of profitability, SBHMY's ROE is +0.11%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, SBHMY is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check IUGNF's competition here
SBHMY vs BTTAY Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, SBHMY is priced at $18.65, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, SBHMY's ROE is +0.11%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, SBHMY is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check BTTAY's competition here
SBHMY vs BRCTF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, SBHMY is priced at $18.65, while BRCTF trades at $19.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas BRCTF's P/E ratio is 17.76. In terms of profitability, SBHMY's ROE is +0.11%, compared to BRCTF's ROE of +0.77%. Regarding short-term risk, SBHMY and BRCTF have similar daily volatility (0.00).Check BRCTF's competition here
SBHMY vs PHMMF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, PHMMF has a market cap of 1.7B. Regarding current trading prices, SBHMY is priced at $18.65, while PHMMF trades at $94.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas PHMMF's P/E ratio is 71.32. In terms of profitability, SBHMY's ROE is +0.11%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, SBHMY and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here
SBHMY vs BIESF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, SBHMY is priced at $18.65, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas BIESF's P/E ratio is -44.44. In terms of profitability, SBHMY's ROE is +0.11%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, SBHMY and BIESF have similar daily volatility (0.00).Check BIESF's competition here
SBHMY vs PPTDF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, PPTDF has a market cap of 1.5B. Regarding current trading prices, SBHMY is priced at $18.65, while PPTDF trades at $11.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas PPTDF's P/E ratio is 15.24. In terms of profitability, SBHMY's ROE is +0.11%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, SBHMY is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check PPTDF's competition here
SBHMY vs CSBTF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, CSBTF has a market cap of 1.5B. Regarding current trading prices, SBHMY is priced at $18.65, while CSBTF trades at $37.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas CSBTF's P/E ratio is -291.54. In terms of profitability, SBHMY's ROE is +0.11%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, SBHMY and CSBTF have similar daily volatility (0.00).Check CSBTF's competition here
SBHMY vs NURPF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, NURPF has a market cap of 1.4B. Regarding current trading prices, SBHMY is priced at $18.65, while NURPF trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas NURPF's P/E ratio is 15.40. In terms of profitability, SBHMY's ROE is +0.11%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, SBHMY and NURPF have similar daily volatility (0.00).Check NURPF's competition here
SBHMY vs ASCLF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, ASCLF has a market cap of 1.3B. Regarding current trading prices, SBHMY is priced at $18.65, while ASCLF trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas ASCLF's P/E ratio is -34.50. In terms of profitability, SBHMY's ROE is +0.11%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, SBHMY is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check ASCLF's competition here
SBHMY vs MEOBF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, MEOBF has a market cap of 1.2B. Regarding current trading prices, SBHMY is priced at $18.65, while MEOBF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas MEOBF's P/E ratio is -16.08. In terms of profitability, SBHMY's ROE is +0.11%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, SBHMY and MEOBF have similar daily volatility (0.00).Check MEOBF's competition here
SBHMY vs SNBIF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, SNBIF has a market cap of 1B. Regarding current trading prices, SBHMY is priced at $18.65, while SNBIF trades at $14.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas SNBIF's P/E ratio is -34.00. In terms of profitability, SBHMY's ROE is +0.11%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, SBHMY is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check SNBIF's competition here
SBHMY vs HBMHF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, HBMHF has a market cap of 766.2M. Regarding current trading prices, SBHMY is priced at $18.65, while HBMHF trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas HBMHF's P/E ratio is 30.16. In terms of profitability, SBHMY's ROE is +0.11%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, SBHMY is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check HBMHF's competition here
SBHMY vs PHGUF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, PHGUF has a market cap of 685.1M. Regarding current trading prices, SBHMY is priced at $18.65, while PHGUF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, SBHMY's ROE is +0.11%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, SBHMY and PHGUF have similar daily volatility (0.00).Check PHGUF's competition here
SBHMY vs INRLF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, INRLF has a market cap of 664.9M. Regarding current trading prices, SBHMY is priced at $18.65, while INRLF trades at $3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas INRLF's P/E ratio is -5.92. In terms of profitability, SBHMY's ROE is +0.11%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, SBHMY and INRLF have similar daily volatility (0.00).Check INRLF's competition here
SBHMY vs BPMUF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, BPMUF has a market cap of 636.8M. Regarding current trading prices, SBHMY is priced at $18.65, while BPMUF trades at $51.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas BPMUF's P/E ratio is 7.05. In terms of profitability, SBHMY's ROE is +0.11%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, SBHMY is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check BPMUF's competition here
SBHMY vs SOLTF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, SOLTF has a market cap of 578.3M. Regarding current trading prices, SBHMY is priced at $18.65, while SOLTF trades at $6.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas SOLTF's P/E ratio is -35.50. In terms of profitability, SBHMY's ROE is +0.11%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, SBHMY and SOLTF have similar daily volatility (0.00).Check SOLTF's competition here
SBHMY vs CLAZF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, CLAZF has a market cap of 531.7M. Regarding current trading prices, SBHMY is priced at $18.65, while CLAZF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas CLAZF's P/E ratio is 0.09. In terms of profitability, SBHMY's ROE is +0.11%, compared to CLAZF's ROE of +0.00%. Regarding short-term risk, SBHMY is less volatile compared to CLAZF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check CLAZF's competition here
SBHMY vs IVEVF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, IVEVF has a market cap of 506.3M. Regarding current trading prices, SBHMY is priced at $18.65, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, SBHMY's ROE is +0.11%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, SBHMY and IVEVF have similar daily volatility (0.00).Check IVEVF's competition here
SBHMY vs CKDXF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, CKDXF has a market cap of 485M. Regarding current trading prices, SBHMY is priced at $18.65, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, SBHMY's ROE is +0.11%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, SBHMY is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check CKDXF's competition here
SBHMY vs GSGTF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, GSGTF has a market cap of 478.2M. Regarding current trading prices, SBHMY is priced at $18.65, while GSGTF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas GSGTF's P/E ratio is -8.16. In terms of profitability, SBHMY's ROE is +0.11%, compared to GSGTF's ROE of +0.78%. Regarding short-term risk, SBHMY is less volatile compared to GSGTF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check GSGTF's competition here
SBHMY vs VBIZF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, VBIZF has a market cap of 472.2M. Regarding current trading prices, SBHMY is priced at $18.65, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, SBHMY's ROE is +0.11%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, SBHMY and VBIZF have similar daily volatility (0.00).Check VBIZF's competition here
SBHMY vs CSPHF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, CSPHF has a market cap of 467.8M. Regarding current trading prices, SBHMY is priced at $18.65, while CSPHF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas CSPHF's P/E ratio is -32.10. In terms of profitability, SBHMY's ROE is +0.11%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, SBHMY is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check CSPHF's competition here
SBHMY vs MDCLF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, MDCLF has a market cap of 463.1M. Regarding current trading prices, SBHMY is priced at $18.65, while MDCLF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas MDCLF's P/E ratio is -10.45. In terms of profitability, SBHMY's ROE is +0.11%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, SBHMY is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check MDCLF's competition here
SBHMY vs RAONF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, SBHMY is priced at $18.65, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas RAONF's P/E ratio is -43.33. In terms of profitability, SBHMY's ROE is +0.11%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, SBHMY is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check RAONF's competition here
SBHMY vs PRNAF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, PRNAF has a market cap of 448.1M. Regarding current trading prices, SBHMY is priced at $18.65, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, SBHMY's ROE is +0.11%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, SBHMY and PRNAF have similar daily volatility (0.00).Check PRNAF's competition here
SBHMY vs BOVNF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, SBHMY is priced at $18.65, while BOVNF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas BOVNF's P/E ratio is -8.84. In terms of profitability, SBHMY's ROE is +0.11%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, SBHMY is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check BOVNF's competition here
SBHMY vs TBGNF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, SBHMY is priced at $18.65, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, SBHMY's ROE is +0.11%, compared to TBGNF's ROE of N/A. Regarding short-term risk, SBHMY and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
SBHMY vs CLVLF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, CLVLF has a market cap of 401M. Regarding current trading prices, SBHMY is priced at $18.65, while CLVLF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas CLVLF's P/E ratio is 15.69. In terms of profitability, SBHMY's ROE is +0.11%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, SBHMY and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
SBHMY vs PTCHF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, PTCHF has a market cap of 396.4M. Regarding current trading prices, SBHMY is priced at $18.65, while PTCHF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas PTCHF's P/E ratio is 7.86. In terms of profitability, SBHMY's ROE is +0.11%, compared to PTCHF's ROE of +0.15%. Regarding short-term risk, SBHMY and PTCHF have similar daily volatility (0.00).Check PTCHF's competition here
SBHMY vs CLVLY Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, CLVLY has a market cap of 389.5M. Regarding current trading prices, SBHMY is priced at $18.65, while CLVLY trades at $7.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas CLVLY's P/E ratio is 15.06. In terms of profitability, SBHMY's ROE is +0.11%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, SBHMY is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check CLVLY's competition here
SBHMY vs NWBO Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, NWBO has a market cap of 370M. Regarding current trading prices, SBHMY is priced at $18.65, while NWBO trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas NWBO's P/E ratio is -4.23. In terms of profitability, SBHMY's ROE is +0.11%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, SBHMY is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check NWBO's competition here
SBHMY vs CLTEF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, CLTEF has a market cap of 361M. Regarding current trading prices, SBHMY is priced at $18.65, while CLTEF trades at $5.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas CLTEF's P/E ratio is -5.05. In terms of profitability, SBHMY's ROE is +0.11%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, SBHMY and CLTEF have similar daily volatility (0.00).Check CLTEF's competition here
SBHMY vs CYDY Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, CYDY has a market cap of 352.5M. Regarding current trading prices, SBHMY is priced at $18.65, while CYDY trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas CYDY's P/E ratio is -14.30. In terms of profitability, SBHMY's ROE is +0.11%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, SBHMY is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check CYDY's competition here
SBHMY vs HLOSF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, HLOSF has a market cap of 346.9M. Regarding current trading prices, SBHMY is priced at $18.65, while HLOSF trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas HLOSF's P/E ratio is -10.23. In terms of profitability, SBHMY's ROE is +0.11%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, SBHMY and HLOSF have similar daily volatility (0.00).Check HLOSF's competition here
SBHMY vs PRRUF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, PRRUF has a market cap of 324.5M. Regarding current trading prices, SBHMY is priced at $18.65, while PRRUF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas PRRUF's P/E ratio is -11.05. In terms of profitability, SBHMY's ROE is +0.11%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, SBHMY and PRRUF have similar daily volatility (0.00).Check PRRUF's competition here
SBHMY vs IDRSF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, IDRSF has a market cap of 306.2M. Regarding current trading prices, SBHMY is priced at $18.65, while IDRSF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas IDRSF's P/E ratio is -0.88. In terms of profitability, SBHMY's ROE is +0.11%, compared to IDRSF's ROE of +0.20%. Regarding short-term risk, SBHMY is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check IDRSF's competition here
SBHMY vs BXPHF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, BXPHF has a market cap of 294.2M. Regarding current trading prices, SBHMY is priced at $18.65, while BXPHF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas BXPHF's P/E ratio is -15.00. In terms of profitability, SBHMY's ROE is +0.11%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, SBHMY and BXPHF have similar daily volatility (0.00).Check BXPHF's competition here
SBHMY vs PBBIF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, SBHMY is priced at $18.65, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, SBHMY's ROE is +0.11%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, SBHMY is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check PBBIF's competition here
SBHMY vs HNSBF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, HNSBF has a market cap of 279.7M. Regarding current trading prices, SBHMY is priced at $18.65, while HNSBF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas HNSBF's P/E ratio is -3.67. In terms of profitability, SBHMY's ROE is +0.11%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, SBHMY is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check HNSBF's competition here
SBHMY vs GNFTF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, GNFTF has a market cap of 276.4M. Regarding current trading prices, SBHMY is priced at $18.65, while GNFTF trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas GNFTF's P/E ratio is 138.75. In terms of profitability, SBHMY's ROE is +0.11%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, SBHMY is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check GNFTF's competition here
SBHMY vs AVCTF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, AVCTF has a market cap of 269.3M. Regarding current trading prices, SBHMY is priced at $18.65, while AVCTF trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas AVCTF's P/E ratio is -5.59. In terms of profitability, SBHMY's ROE is +0.11%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, SBHMY and AVCTF have similar daily volatility (0.00).Check AVCTF's competition here
SBHMY vs TRGNF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, TRGNF has a market cap of 264.8M. Regarding current trading prices, SBHMY is priced at $18.65, while TRGNF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas TRGNF's P/E ratio is -5.88. In terms of profitability, SBHMY's ROE is +0.11%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, SBHMY is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check TRGNF's competition here
SBHMY vs OPORF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, OPORF has a market cap of 240.5M. Regarding current trading prices, SBHMY is priced at $18.65, while OPORF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas OPORF's P/E ratio is 17.50. In terms of profitability, SBHMY's ROE is +0.11%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, SBHMY and OPORF have similar daily volatility (0.00).Check OPORF's competition here
SBHMY vs SPHDF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, SPHDF has a market cap of 237.9M. Regarding current trading prices, SBHMY is priced at $18.65, while SPHDF trades at $18.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas SPHDF's P/E ratio is -3.95. In terms of profitability, SBHMY's ROE is +0.11%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, SBHMY is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check SPHDF's competition here
SBHMY vs ORYZF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, SBHMY is priced at $18.65, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, SBHMY's ROE is +0.11%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, SBHMY and ORYZF have similar daily volatility (0.00).Check ORYZF's competition here
SBHMY vs NWPHF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, SBHMY is priced at $18.65, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas NWPHF's P/E ratio is N/A. In terms of profitability, SBHMY's ROE is +0.11%, compared to NWPHF's ROE of N/A. Regarding short-term risk, SBHMY and NWPHF have similar daily volatility (0.00).Check NWPHF's competition here
SBHMY vs SLNCF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, SBHMY is priced at $18.65, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas SLNCF's P/E ratio is -3.14. In terms of profitability, SBHMY's ROE is +0.11%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, SBHMY is less volatile compared to SLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check SLNCF's competition here
SBHMY vs FPHAF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, SBHMY is priced at $18.65, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, SBHMY's ROE is +0.11%, compared to FPHAF's ROE of N/A. Regarding short-term risk, SBHMY and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here
SBHMY vs VSBC Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, SBHMY is priced at $18.65, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas VSBC's P/E ratio is N/A. In terms of profitability, SBHMY's ROE is +0.11%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, SBHMY and VSBC have similar daily volatility (0.00).Check VSBC's competition here
SBHMY vs FGHQF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, SBHMY is priced at $18.65, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, SBHMY's ROE is +0.11%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, SBHMY is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check FGHQF's competition here
SBHMY vs RECEF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, RECEF has a market cap of 192.9M. Regarding current trading prices, SBHMY is priced at $18.65, while RECEF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas RECEF's P/E ratio is -8.33. In terms of profitability, SBHMY's ROE is +0.11%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, SBHMY is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check RECEF's competition here
SBHMY vs AMGXF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, AMGXF has a market cap of 191.3M. Regarding current trading prices, SBHMY is priced at $18.65, while AMGXF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas AMGXF's P/E ratio is -0.69. In terms of profitability, SBHMY's ROE is +0.11%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, SBHMY is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check AMGXF's competition here
SBHMY vs CMVLF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, CMVLF has a market cap of 187.4M. Regarding current trading prices, SBHMY is priced at $18.65, while CMVLF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas CMVLF's P/E ratio is -3.88. In terms of profitability, SBHMY's ROE is +0.11%, compared to CMVLF's ROE of -0.46%. Regarding short-term risk, SBHMY is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check CMVLF's competition here
SBHMY vs NGENF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, NGENF has a market cap of 186.6M. Regarding current trading prices, SBHMY is priced at $18.65, while NGENF trades at $2.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas NGENF's P/E ratio is -9.14. In terms of profitability, SBHMY's ROE is +0.11%, compared to NGENF's ROE of -4.00%. Regarding short-term risk, SBHMY is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check NGENF's competition here
SBHMY vs BSEM Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, BSEM has a market cap of 181.7M. Regarding current trading prices, SBHMY is priced at $18.65, while BSEM trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas BSEM's P/E ratio is 7.56. In terms of profitability, SBHMY's ROE is +0.11%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, SBHMY is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check BSEM's competition here
SBHMY vs IPHYF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, IPHYF has a market cap of 179.7M. Regarding current trading prices, SBHMY is priced at $18.65, while IPHYF trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas IPHYF's P/E ratio is -2.71. In terms of profitability, SBHMY's ROE is +0.11%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, SBHMY is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check IPHYF's competition here
SBHMY vs ADOCY Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, SBHMY is priced at $18.65, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, SBHMY's ROE is +0.11%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, SBHMY and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
SBHMY vs BRIBF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, BRIBF has a market cap of 169.3M. Regarding current trading prices, SBHMY is priced at $18.65, while BRIBF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas BRIBF's P/E ratio is -2.31. In terms of profitability, SBHMY's ROE is +0.11%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, SBHMY is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check BRIBF's competition here
SBHMY vs MLLCF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, SBHMY is priced at $18.65, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas MLLCF's P/E ratio is -1.98. In terms of profitability, SBHMY's ROE is +0.11%, compared to MLLCF's ROE of -0.42%. Regarding short-term risk, SBHMY is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check MLLCF's competition here
SBHMY vs HOFBF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, HOFBF has a market cap of 130.4M. Regarding current trading prices, SBHMY is priced at $18.65, while HOFBF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas HOFBF's P/E ratio is -11.00. In terms of profitability, SBHMY's ROE is +0.11%, compared to HOFBF's ROE of -1.54%. Regarding short-term risk, SBHMY is less volatile compared to HOFBF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check HOFBF's competition here
SBHMY vs AAPGV Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, SBHMY is priced at $18.65, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas AAPGV's P/E ratio is N/A. In terms of profitability, SBHMY's ROE is +0.11%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, SBHMY is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check AAPGV's competition here
SBHMY vs PBIGF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, PBIGF has a market cap of 125.9M. Regarding current trading prices, SBHMY is priced at $18.65, while PBIGF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas PBIGF's P/E ratio is -7.92. In terms of profitability, SBHMY's ROE is +0.11%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, SBHMY and PBIGF have similar daily volatility (0.00).Check PBIGF's competition here
SBHMY vs SCNLF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, SCNLF has a market cap of 123.5M. Regarding current trading prices, SBHMY is priced at $18.65, while SCNLF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas SCNLF's P/E ratio is -3.97. In terms of profitability, SBHMY's ROE is +0.11%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, SBHMY is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check SCNLF's competition here
SBHMY vs PSTTF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, SBHMY is priced at $18.65, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, SBHMY's ROE is +0.11%, compared to PSTTF's ROE of N/A. Regarding short-term risk, SBHMY and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
SBHMY vs EPRXF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, SBHMY is priced at $18.65, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, SBHMY's ROE is +0.11%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, SBHMY is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check EPRXF's competition here
SBHMY vs POLBF Comparison July 2025
SBHMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBHMY stands at 16.7B. In comparison, POLBF has a market cap of 105.3M. Regarding current trading prices, SBHMY is priced at $18.65, while POLBF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBHMY currently has a P/E ratio of 64.31, whereas POLBF's P/E ratio is -7.55. In terms of profitability, SBHMY's ROE is +0.11%, compared to POLBF's ROE of -0.33%. Regarding short-term risk, SBHMY is less volatile compared to POLBF. This indicates potentially lower risk in terms of short-term price fluctuations for SBHMY.Check POLBF's competition here